The deal gives clinicians in PathNet's national lab network access to Valar's AI-powered Vesta diagnostic portfolio for non-muscle invasive bladder cancer.

Focused deployments across Illinois, Virginia, Delaware, and North Carolina, combined with flat-fee DC fast charging pilots, position the company for accelerated growth in 2026 PLANO, TX / ACCESS ...

NEW YORK, NY / ACCESS Newswire / December 23, 2025 / The digital revolution promised transparency for commodities. Gold proved that the endpoint was more difficult to reach through pure ambition. The ...

This study provides important evidence that negative affect is associated with slower cognitive processing in daily life, with findings replicated across three independent samples and supported by ...

TrinScreen HIV order signals renewed strength in global HIV testing market- Company also reports a key milestone of Adjusted EBITDA 1 positive operations in Q3 2025 and expects ...